These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17925012)

  • 1. Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis.
    Misra A; Chattopadhyay P; Chosdol K; Sarkar C; Mahapatra AK; Sinha S
    BMC Cancer; 2007 Oct; 7():190. PubMed ID: 17925012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations.
    Misra A; Chattopadhyay P; Dinda AK; Sarkar C; Mahapatra AK; Hasnain SE; Sinha S
    J Neurooncol; 2000 May; 48(1):1-12. PubMed ID: 11026691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors.
    Chosdol K; Misra A; Puri S; Srivastava T; Chattopadhyay P; Sarkar C; Mahapatra AK; Sinha S
    BMC Cancer; 2009 Jan; 9():5. PubMed ID: 19126244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations.
    Liu XY; Gerges N; Korshunov A; Sabha N; Khuong-Quang DA; Fontebasso AM; Fleming A; Hadjadj D; Schwartzentruber J; Majewski J; Dong Z; Siegel P; Albrecht S; Croul S; Jones DT; Kool M; Tonjes M; Reifenberger G; Faury D; Zadeh G; Pfister S; Jabado N
    Acta Neuropathol; 2012 Nov; 124(5):615-25. PubMed ID: 22886134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
    Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
    Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
    Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
    Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of gliomas.
    Kattar MM; Kupsky WJ; Shimoyama RK; Vo TD; Olson MW; Bargar GR; Sarkar FH
    Hum Pathol; 1997 Oct; 28(10):1166-79. PubMed ID: 9343324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDH mutations in older patients with diffuse astrocytic gliomas.
    Andrews C; Prayson RA
    Ann Diagn Pathol; 2020 Dec; 49():151653. PubMed ID: 33137656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas.
    Bartkova J; Hamerlik P; Stockhausen MT; Ehrmann J; Hlobilkova A; Laursen H; Kalita O; Kolar Z; Poulsen HS; Broholm H; Lukas J; Bartek J
    Oncogene; 2010 Sep; 29(36):5095-102. PubMed ID: 20581868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry.
    Koga H; Zhang S; Kumanishi T; Washiyama K; Ichikawa T; Tanaka R; Mukawa J
    Acta Neuropathol; 1994; 87(3):225-32. PubMed ID: 8009954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
    Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-alu PCR detects high frequency of genetic alterations in glioma cells exposed to sub-lethal cisplatin.
    Srivastava T; Seth A; Datta K; Chosdol K; Chattopadhyay P; Sinha S
    Int J Cancer; 2005 Nov; 117(4):683-9. PubMed ID: 15912534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.
    Rickman DS; Bobek MP; Misek DE; Kuick R; Blaivas M; Kurnit DM; Taylor J; Hanash SM
    Cancer Res; 2001 Sep; 61(18):6885-91. PubMed ID: 11559565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.
    Mochizuki S; Iwadate Y; Namba H; Yoshida Y; Yamaura A; Sakiyama S; Tagawa M
    Int J Oncol; 1999 Nov; 15(5):983-9. PubMed ID: 10536183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.
    van Meyel DJ; Ramsay DA; Casson AG; Keeney M; Chambers AF; Cairncross JG
    J Natl Cancer Inst; 1994 Jul; 86(13):1011-7. PubMed ID: 8007011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.